Lady Parts: Bruce E. Katz, MD, Ushers in Cosmetic Surgery’s Final Frontier
In the November PSP cover story, Bruce E. Katz, MD, talks about how he's helping to usher in cosmetic surgery's final frontier--vaginal rejuvenation.
In the November PSP cover story, Bruce E. Katz, MD, talks about how he's helping to usher in cosmetic surgery's final frontier--vaginal rejuvenation.
Evolus has submitted the final module of its PMA application to the FDA for Evolysse Sculpt, an injectable HA gel for mid-face volume restoration.
The alliance aims to improve pre- and post-operative care and establish new recovery standards.
Revance Therapeutics received FDA approval for Daxxify to be used as an injectable to improve moderate to severe frown lines in adults.
Read MoreThe FDA has accepted Revance’s BLA resubmission for DaxibotulinumtoxinA for Injection, designed to treat severe glabellar lines.
Read MoreAllergan Aesthetics is celebrating Botox’s 20th anniversary as an FDA-approved product with a cross-country art installation.
Read MoreApyx Medical Corp.—developer of Helium Plasma Technology, which is marketed and sold as Renuvion® in the cosmetic surgery market —has been notified by the U.S. FDA that the agency intends to post a Medical Device Safety Communication related to the Apyx Medical’s Advanced Energy products.
Read MoreRevance Therapeutics Inc, a biotechnology company focused on innovative aesthetic and therapeutic...
Read MoreThe U.S. FDA’s final guidance describes the steps companies should take, before a recall is necessary, to develop recall policies and procedures that include training, planning and record-keeping to reduce the time a recalled product is on the market.
Read MoreAn advisory panel on general and plastic surgery voted against recommending FDA approval of Integra LifeSciences’ SurgiMend mesh for the specific indication of breast reconstruction, even though the device has been used in breast reconstruction for more than a decade under a 510(k) clearance, MD+DI reports.
Read MoreThe U.S. Food and Drug Administration took several new actions to strengthen breast implant risk communication and help those who are considering breast implants make informed decisions, according to a news release.
Read MoreThe US Food and Drug Administration (FDA) has approved the Spatz3 Gastric Balloon, an adjustable gastric balloon system, to aid in weight loss for adult patients struggling with obesity, Spatz FGIA Inc announces in a news release.
Read MoreThe American Society for Dermatologic Surgery Association supports the U.S. Food and Drug Administration’s safety communication regarding needle-less devices, such as hyaluron pens (HA pens) for injection of dermal fillers.
Read MoreR2 Technologies Inc, a provider of CryoAesthetic medical devices, announces that its in-office system, Glacial Rx, is now FDA-cleared for general dermabrasion, scar and acne scar revision, and tattoo removal.
Read MoreIf you are thinking about having a microneedling procedure, the U.S. Food and Drug Administration recommends you choose a health care provider who is specially trained in microneedling.
Read MoreCytrellis just received the green light for the device, which it’s named the ellacor system with Micro-Coring technology, NewBeauty reports.
Read MoreClearance of the Micro-Coring technology provides a new anti-aging aesthetic skin treatment category, designed to provide a faster healing time without burns or scarring.
Read MoreAesthetics Biomedical announces that the Vivace RF Microneedling device is now cleared for use at both the 1MHz and the 2MHz frequency.
Read More